Chemoimmunotherapy for advanced ovarian carcinoma with adriamycin-cyclophosphamide +/- BCG: early report of a Southwest Oncology Group study.

David S Alberts, S. E. Salmon, T. E. Moon

Research output: Contribution to journalArticle

6 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)160-165
Number of pages6
JournalRecent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer
Volume68
StatePublished - 1978
Externally publishedYes

Fingerprint

Drug Administration Schedule
BCG Vaccine
Neoplasm Staging
Mycobacterium bovis
Combination Drug Therapy
Ovarian Neoplasms
Doxorubicin
Cyclophosphamide
Carcinoma
Immunotherapy
Immunologic Adjuvants
Drug Therapy
Therapeutics
Adjuvant Chemotherapy
Radiotherapy
Survival Rate
Macrophages
Observation
Recurrence
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{a287d796afae4a0ca3563891172455aa,
title = "Chemoimmunotherapy for advanced ovarian carcinoma with adriamycin-cyclophosphamide +/- BCG: early report of a Southwest Oncology Group study.",
author = "Alberts, {David S} and Salmon, {S. E.} and Moon, {T. E.}",
year = "1978",
language = "English (US)",
volume = "68",
pages = "160--165",
journal = "Recent Results in Cancer Research",
issn = "0080-0015",
publisher = "Springer New York",

}

TY - JOUR

T1 - Chemoimmunotherapy for advanced ovarian carcinoma with adriamycin-cyclophosphamide +/- BCG

T2 - early report of a Southwest Oncology Group study.

AU - Alberts, David S

AU - Salmon, S. E.

AU - Moon, T. E.

PY - 1978

Y1 - 1978

UR - http://www.scopus.com/inward/record.url?scp=0018255304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018255304&partnerID=8YFLogxK

M3 - Article

C2 - 752854

AN - SCOPUS:0018255304

VL - 68

SP - 160

EP - 165

JO - Recent Results in Cancer Research

JF - Recent Results in Cancer Research

SN - 0080-0015

ER -